Nitrogen

Envelope surface glycoprotein gp160, precursor ; Human immunodeficiency virus 1







44 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 30658057 Systematic mutational analysis of human neutrophil α-defensin HNP4. 2019 Apr 1 1
2 31550607 Replication of HIV-1 envelope protein cytoplasmic domain variants in permissive and restrictive cells. 2019 Dec 1
3 26384088 Short Communication: The Distribution of Potential N-Linked Glycosylation Sites in Gp120 Differs Among Major HIV-1 Subtypes Circulating in China. 2016 Jan 1
4 26121645 Several N-Glycans on the HIV Envelope Glycoprotein gp120 Preferentially Locate Near Disulphide Bridges and Are Required for Efficient Infectivity and Virus Transmission. 2015 1
5 26577736 Effective isotope labeling of proteins in a mammalian expression system. 2015 1
6 25016576 Characterization of a monoclonal antibody to a novel glycan-dependent epitope in the V1/V2 domain of the HIV-1 envelope protein, gp120. 2014 Nov 1
7 25275130 HIV-1 envelope glycan moieties modulate HIV-1 transmission. 2014 Dec 1
8 25285362 Mass spectrometry approach and ELISA reveal the effect of codon optimization on N-linked glycosylation of HIV-1 gp120. 2014 Dec 5 1
9 23384254 A systematic study of the N-glycosylation sites of HIV-1 envelope protein on infectivity and antibody-mediated neutralization. 2013 Feb 6 1
10 22842622 Use of (alternative) coreceptors for HIV entry. 2012 Sep 1
11 21593147 Longer V1V2 region with increased number of potential N-linked glycosylation sites in the HIV-1 envelope glycoprotein protects against HIV-specific neutralizing antibodies. 2011 Jul 1
12 21674342 On-resin convergent synthesis of a glycopeptide from HIV gp120 containing a high mannose type N-linked oligosaccharide. 2011 1
13 24159466 Neutralizing Antibody Responses and Evolution of the Viral Envelope in the Course of HIV-1 Korean Clade B Infection. 2011 Dec 1
14 18322210 Identification of an N-linked glycosylation in the C4 region of HIV-1 envelope gp120 that is critical for recognition of neighboring CD4 T cell epitopes. 2008 Mar 15 1
15 18691028 Levels of N-linked glycosylation on the V1 loop of HIV-1 Env proteins and their relationship to the antigenicity of Env from primary viral isolates. 2008 Jun 1
16 17050611 Pradimicin A, a carbohydrate-binding nonpeptidic lead compound for treatment of infections with viruses with highly glycosylated envelopes, such as human immunodeficiency virus. 2007 Jan 1
17 17269927 Defining carbohydrate antigens as HIV vaccine candidates. 2007 3
18 17508782 Structural analysis of the HIV-1 gp120 V3 loop: application to the HIV-Haiti isolates. 2007 Jun 1
19 16547752 N-Glycans in the gp120 V1/V2 domain of the HIV-1 strain NL4-3 are indispensable for viral infectivity and resistance against antibody neutralization. 2006 Sep 1
20 16889861 A hybridoma-based in vitro translation system that efficiently synthesizes glycoproteins. 2006 Dec 15 1
21 15016849 N-linked glycosylation of the V3 loop and the immunologically silent face of gp120 protects human immunodeficiency virus type 1 SF162 from neutralization by anti-gp120 and anti-gp41 antibodies. 2004 Apr 1
22 15183061 N-linked glycosylation in the CXCR4 N-terminus inhibits binding to HIV-1 envelope glycoproteins. 2004 Jun 20 4
23 15542540 Improved design of an antigen with enhanced specificity for the broadly HIV-neutralizing antibody b12. 2004 Oct 1
24 12734200 Characterization of the oligosaccharides associated with the human ovarian tumor marker CA125. 2003 Aug 1 1
25 12487819 High mannose glycans and sialic acid on gp120 regulate binding of mannose-binding lectin (MBL) to HIV type 1. 2002 Nov 20 1
26 12504579 Adaptation of a CXCR4-using human immunodeficiency type 1 NDK virus in intestinal cells is associated with CD4-independent replication. 2002 Dec 20 1
27 11278567 N-linked glycosylation of the HIV type-1 gp120 envelope glycoprotein as a major determinant of CCR5 and CXCR4 coreceptor utilization. 2001 Apr 20 1
28 11302743 Myristoylation of human immunodeficiency virus type 1 gag protein is required for efficient env protein transportation to the surface of cells. 2001 Apr 20 1
29 11390601 N-linked glycosylation sites adjacent to and within the V1/V2 and the V3 loops of dualtropic human immunodeficiency virus type 1 isolate DH12 gp120 affect coreceptor usage and cellular tropism. 2001 Jul 1
30 11485624 Protection of neutralization epitopes in the V3 loop of oligomeric human immunodeficiency virus type 1 glycoprotein 120 by N-linked oligosaccharides in the V1 region. 2001 Jul 20 1
31 11672902 Enhanced immunogenicity of a human immunodeficiency virus type 1 env DNA vaccine by manipulating N-glycosylation signals. Effects of elimination of the V3 N306 glycan. 2001 Nov 12 1
32 11007268 Selective and facile cyclization of N-chloroacetylated peptides from the C4 domain of HIV Gp120 in LiCl/DMF solvent systems. 2000 Sep 1
33 10413093 The N-linked glycan of the V3 region of HIV-1 gp120 and CXCR4-dependent multiplication of a human immunodeficiency virus type 1 lymphocyte-tropic variant. 1999 Jul 2 1
34 9829637 Concanavalin A-immobilized polystyrene nanospheres capture HIV-1 virions and gp120: potential approach towards prevention of viral transmission. 1998 Dec 1
35 21374492 Inhibition of HIV Infection by Lectin Binding to gp120. 1998 1
36 8523579 Single amino acid substitution in constant region 1 or 4 of gp120 causes the phenotype of a human immunodeficiency virus type 1 variant with mutations in hypervariable regions 1 and 2 to revert. 1996 Jan 1
37 8615025 Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines. 1996 Apr 1 1
38 8790377 Effects of inefficient cleavage of the signal sequence of HIV-1 gp 120 on its association with calnexin, folding, and intracellular transport. 1996 Sep 3 1
39 7832633 Identification of an N-linked glycan in the V1-loop of HIV-1 gp120 influencing neutralization by anti-V3 antibodies and soluble CD4. 1994 1
40 8207403 Deletion of a single N-linked glycosylation site from the transmembrane envelope protein of human immunodeficiency virus type 1 stops cleavage and transport of gp160 preventing env-mediated fusion. 1994 Jun 2
41 8218172 Site-specific N-glycosylation and oligosaccharide structures of recombinant HIV-1 gp120 derived from a baculovirus expression system. 1993 Oct 19 2
42 8416385 Glycosylation is necessary for the correct folding of human immunodeficiency virus gp120 in CD4 binding. 1993 Jan 4
43 1549584 Nonrandom distribution of gp120 N-linked glycosylation sites important for infectivity of human immunodeficiency virus type 1. 1992 Mar 15 6
44 2082620 Mutation of conserved N-glycosylation sites around the CD4-binding site of human immunodeficiency virus type 1 GP120 affects viral infectivity. 1990 Dec 1